Wu Y Y
Beijing Hospital.
Zhonghua Fu Chan Ke Za Zhi. 1993 Sep;28(9):539-41, 569-70.
Climacteric symptoms were treated with Org OD14 in 30 women. Each patient received 2.5 mg/day orally, for 90 consecutive days in 6 cases and 120 consecutive days in 24 cases. The results demonstrated a good clinical effect with a significant difference in Kupperman's score is 26.67 +/- 9.97 t 5.06 +/- 3.95 before and after treatment. The fasting urinary calcium/creatinine and urinary hydroxyproline/creatinine ratios, blood triglyceride and cholesterol levels decreased, vaginal cytology showed estrogenic effects during therapy. In 2 of 20 patients the endometrium changed from atrophic before treatment to slightly proliferative phase after treatment. The clinical use of org OD14 for perimenopaused women was discussed.
用Org OD14治疗30例更年期妇女的更年期症状。6例患者每天口服2.5毫克,连续服用90天,24例患者连续服用120天。结果显示临床效果良好,治疗前后Kupperman评分有显著差异,分别为26.67±9.97和5.06±3.95。空腹尿钙/肌酐和尿羟脯氨酸/肌酐比值、血甘油三酯和胆固醇水平降低,阴道细胞学检查显示治疗期间有雌激素作用。20例患者中有2例子宫内膜从治疗前的萎缩期变为治疗后的轻度增殖期。讨论了Org OD14在围绝经期妇女中的临床应用。